Kenilworth, NJ, United States of America

Feng Liang


Average Co-Inventor Count = 6.7

ph-index = 5

Forward Citations = 68(Granted Patents)


Location History:

  • Tallahassee, FL (US) (1995)
  • Durham, NC (US) (1997 - 2002)
  • Kenilworth, NJ (US) (2003 - 2006)

Company Filing History:


Years Active: 1995-2006

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovations by Inventor Feng Liang

Introduction

Feng Liang, an esteemed inventor based in Kenilworth, New Jersey, has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of taxane compounds. With an impressive portfolio of 11 patents, Liang's work showcases his dedication to advancing medical innovations that have the potential to impact cancer treatment.

Latest Patents

Among Liang's latest patents are the 1-deoxy taxol analogs, including 1-Deoxybaccatin III, 1-deoxytaxol, and their preparation methods. These patents highlight his focus on creating new analogs that can provide enhanced therapeutic benefits. Additionally, he has worked on the synthesis of tricyclic and tetracyclic taxane intermediates, which are crucial for the production of taxol and other important taxanes.

Career Highlights

Feng Liang is currently affiliated with the Florida State University Research Foundation, Inc., where he conducts research aimed at improving drug formulations and therapeutic strategies. His work is recognized within the academic and scientific communities, and he has been a key player in many transformative projects.

Collaborations

Liang's innovations have been supported by collaborations with notable colleagues, including Robert A. Holton and Carmen Somoza. These partnerships have facilitated the exchange of ideas and expertise, leading to advancements in taxane research and development.

Conclusion

In summary, Feng Liang's contributions to pharmaceutical chemistry through his 11 patents demonstrate his significant role as an inventor and researcher. His ongoing work at the Florida State University Research Foundation, Inc. continues to push the boundaries of drug development, particularly in the fight against cancer. With a focus on creating innovative solutions, Liang exemplifies the spirit of inventiveness and collaboration that drives scientific progress.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…